SEC Filings | Constellation Pharmaceuticals

SEC Filings

Filing date	Form	Description	Filing Group	View
Oct 11, 2018	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-18-297014.pdf 0001193125-18-297014.rtf 0001193125-18-297014.xls View HTML
Sep 05, 2018	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0000899243-18-023858.pdf 0000899243-18-023858.rtf View HTML
Sep 05, 2018	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-18-023860.pdf 0000899243-18-023860.rtf View HTML
Sep 05, 2018	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0000899243-18-023859.pdf 0000899243-18-023859.rtf View HTML
Sep 05, 2018	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-18-023861.pdf 0000899243-18-023861.rtf View HTML
Sep 04, 2018	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-18-266308.pdf 0001193125-18-266308.rtf 0001193125-18-266308.xls View HTML
Aug 24, 2018	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-18-023214.pdf 0000899243-18-023214.rtf View HTML
Aug 24, 2018	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-18-023212.pdf 0000899243-18-023212.rtf View HTML
Aug 14, 2018	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-18-248519.pdf 0001193125-18-248519.rtf 0001193125-18-248519.xls View HTML
Aug 14, 2018	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001193125-18-248533.pdf 0001193125-18-248533.rtf 0001193125-18-248533.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Copyright Morningstar